Psychemedics Corporation (NASDAQ:PMD) announced a quarterly dividend on Thursday, August 3rd, Wall Street Journal reports. Stockholders of record on Monday, August 14th will be paid a dividend of 0.15 per share on Thursday, August 24th. This represents a $0.60 annualized dividend and a dividend yield of 2.94%. The ex-dividend date of this dividend is Thursday, August 10th.
Shares of Psychemedics Corporation (PMD) traded up 1.14% during mid-day trading on Friday, hitting $20.43. 59,523 shares of the stock traded hands. The company has a market cap of $112.18 million, a price-to-earnings ratio of 15.08 and a beta of 1.00. Psychemedics Corporation has a 52 week low of $13.81 and a 52 week high of $27.99. The stock has a 50-day moving average of $24.17 and a 200-day moving average of $21.67.
Psychemedics Corporation (NASDAQ:PMD) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $0.16 earnings per share for the quarter. The business had revenue of $9.68 million for the quarter. Psychemedics Corporation had a net margin of 17.59% and a return on equity of 47.94%. Analysts anticipate that Psychemedics Corporation will post $0.93 EPS for the current year.
WARNING: This piece was originally reported by BNB Daily and is owned by of BNB Daily. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.baseball-news-blog.com/2017/08/19/psychemedics-corporation-nasdaqpmd-to-go-ex-dividend-on-august-10th-updated.html.
About Psychemedics Corporation
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.
Receive News & Ratings for Psychemedics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corporation and related companies with MarketBeat.com's FREE daily email newsletter.